- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01923350
Avoiding Diabetes After Pregnancy Trial (ADAPT)
Increasing Adoption of Early Intervention to Prevent Diabetes After Gestational Diabetes Mellitus
The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM).
The study was conducted as an integrated trial with two separate arms: one to facilitate weight reduction and the other to increase diabetes testing.
There were two hypotheses:
- Women in the testing intervention will be more likely to have received a diabetes test within the 6 months post-intervention than women in the control group.
- Women in the weight reduction intervention will have lost more weight at the 6-month and 9-month follow-up than women in the control group.
The primary study aim was to determine the efficacy of a system of interactive technology-based supports to prompt women with a history of gestational diabetes to take steps to prevent diabetes. The secondary aims were focused on women's engagement:
- To evaluate the impact of the weight reduction intervention in terms of participant engagement with the interactive technology-based supports.
- To evaluate changes in the women's perception of their personal diabetes risk following after exposure to information about diabetes risk following a pregnancy with GDM.
- To identify the determinants and motivators of and barriers to diabetes testing in the 6- to 12-week postpartum period and thereafter, using the Health Belief model to guide the study.
There was an additional secondary aim involving metformin:
- To evaluate the impact of the diabetes risk reduction intervention in terms of women seeking out their physician's advice on metformin treatment and receiving a metformin prescription, if appropriate.
Przegląd badań
Status
Warunki
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Maryland
-
Silver Spring, Maryland, Stany Zjednoczone, 20910
- Social & Scientific Systems Inc.
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
General
- History of GDM in the previous 6 months to 4.5 years
- Access to the internet and text messages or phone messages
- Current patient of Harvard Vanguard Medical Associates
- 18 years of age or older
- Able to read in English
Weight Reduction Group
- Overweight or obese
- Capable of performing moderate physical activity
Diabetes Testing Group
- Had not competed a diabetes test (OGTT or fasting blood sugar at 6-12 weeks postpartum or OGTT, fasting blood sugar or hemoglobin A1c after 12 weeks postpartum)
Exclusion Criteria:
General:
- Diabetes diagnosis
- Psychotic disorder diagnosis
- Enrolled in a research study
Weight Reduction Group
- Taking prescription medications for weight loss
- Engaged in a formal weight reduction program
Diabetes Testing Group
- History of postpartum OGTT, fasting plasma glucose or hemoglobin A1c (after 6 weeks postpartum)
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Weight Reduction Intervention
|
The weight trial intervention components were:
|
Aktywny komparator: Weight Reduction Control Arm
|
Participants received an initial brochure about managing diabetes risk, a digital scale to use in entering their weights in online questionnaires, and monthly emailed wellness messages unrelated to diabetes.
|
Aktywny komparator: Tested for diabetes
|
Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a sub-sample of those tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.
|
Aktywny komparator: Not tested for diabetes
|
Due to small numbers in this group, the planned intervention was changed to a mixed-mode study, using baseline and follow-up self-administered questionnaires and semi-structured questionnaires administered to a subsample of those not tested for diabetes to identify factors differentiating the behavior of women who had and had not been tested for diabetes following a pregnancy with gestational diabetes mellitus.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
For participants in weight group, weight reduction from baseline to 6 months
Ramy czasowe: 6 months
|
Participants reported their weights online at baseline, 3 months, 6 months, and 9 months, and the difference in weight from baseline to 6 months was the primary measure of the intervention's success.
|
6 months
|
In testing group, the number of women receiving a diabetes test per ADA Guidelines in the 6-month post-intervention period
Ramy czasowe: 6 months
|
The number of women who were tested in the 6 months following the intervention was determined from electronic medical records.
|
6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Weight intervention participant engagement with the interactive technology-based supports
Ramy czasowe: 9 months
|
Measured by separate scores for taking part in behavioral support (coaching calls) and electronic feedback (women responding on goal performance via daily text messaging (SMS)or weekly IVR, chosen by the participant).
|
9 months
|
Success of participants in weight intervention arm in achieving behavior change goals.
Ramy czasowe: 9 months
|
Information from daily SMS and weekly IVR responses to questions about participants' success in achieving behavior change goals were used to construct achievement scores.
|
9 months
|
Weight change from baseline to 9 months
Ramy czasowe: 9 months
|
Differences were calculated in weights entered on baseline and 9-month surveys for intervention and control arms in the weight group.
|
9 months
|
Weight change from 6 to 9 months
Ramy czasowe: 3 months
|
Difference in weights recorded in 6-month and 9-month questionnaires was calculated for all participants in the weight group.
|
3 months
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Susan J Griffey, DPh, BSN, Social & Scientific Systems Inc.
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- NDEP-GDM GS10F0381L
- GS10F0381L (Inny numer grantu/finansowania: GSA)
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Weight Reduction Intervention
-
University of North Carolina, Chapel HillWeight Watchers InternationalZakończonyNadwaga i otyłośćStany Zjednoczone
-
Zimmer BiometWycofaneZwyrodnieniowa choroba dyskuStany Zjednoczone
-
Munich Municipal HospitalTechnical University of Munich; University of RegensburgNieznany
-
Medical College of WisconsinRekrutacyjnyCukrzyca typu 2Stany Zjednoczone
-
Medical University of South CarolinaWeight Watchers InternationalZakończonyOtyłość | Nadwaga | Cukrzyca typu 2Stany Zjednoczone
-
University of PennsylvaniaWeight Watchers InternationalZakończony
-
Sarah MorrowLawson Health Research InstituteZakończony
-
University Hospital, GhentZakończony
-
University of British ColumbiaZakończonyNadwaga i otyłość | Dieta KetogenicznaKanada
-
The Miriam HospitalUniversity of Tennessee; Weight Watchers InternationalZakończony